Neuropeptides
Volume 43, Issue 1 , Pages 41-46 , February 2009

Intracerebroventricular infusion of neuropeptide Y modulates VIP secretion in the fasting conscious dog

  • O.E. Anastasiou

      Affiliations

    • Division of Endocrinology and Metabolism, Aristotle University of Thessaloniki, AHEPA Univ. Hospital, S. Kyriakidi 1, 54636 Thessaloniki, Greece
    • Corresponding Author InformationCorresponding author. Tel.: +30 2310 994607; fax: +30 2310 994608.
    • ,
  • M.P. Yavropoulou

      Affiliations

    • Division of Endocrinology and Metabolism, Aristotle University of Thessaloniki, AHEPA Univ. Hospital, S. Kyriakidi 1, 54636 Thessaloniki, Greece
    • ,
  • I. Kesisoglou

      Affiliations

    • Third Surgical Department, Aristotle University of Thessaloniki, AHEPA Univ. Hospital, Greece
    • ,
  • K. Kotsa

      Affiliations

    • Division of Endocrinology and Metabolism, Aristotle University of Thessaloniki, AHEPA Univ. Hospital, S. Kyriakidi 1, 54636 Thessaloniki, Greece
    • ,
  • J.G. Yovos

      Affiliations

    • Division of Endocrinology and Metabolism, Aristotle University of Thessaloniki, AHEPA Univ. Hospital, S. Kyriakidi 1, 54636 Thessaloniki, Greece

Received 22 August 2008 ,Accepted 28 October 2008.

References 

  1. Adeghate E, Ponery AS, Pallot DJ, Singh J. Distribution of vasoactive intestinal polypeptide, neuropeptide Y and substance P and their effects on insulin secretion from the in vitro pancreas of normal and diabetic rats. Peptides. 2001;22:99–107
  2. Bertrand G, Puech R, Maisonnasse Y, Bockaert J, Loubatières-Mariani MM. Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat. Br. J. Pharmacol. 1996;117:764–770
  3. Billington CJ, Briggs JE, Grace M, Levine AS. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am. J. Physiol. 1991;260:321–327
  4. Bishop AE, Polak JM, Green IC, Bryant MG, Bloom SR. The location of VIP in the pancreas of man and rat. Diabetologia. 1980;18:73–78
  5. Chayvialle JA, Miyata M, Rayford PL, Thompson JC. Effects of test meal, intragastric nutrients, and intraduodenal bile on plasma concentrations of immunoreactive somatostatin and vasoactive intestinal peptide in dogs. Gastroenterology. 1980;79:844–852
  6. Cho YR, Kim CW. Neuropeptide Y promotes B cell replication via extracellular signal-regulated kinase activation. Biochem. Biophys. Res. Commun. 2004;314:773–780
  7. Dunbar JC, Ergene E, Barraco RA. Neuropeptide-Y stimulation of insulin secretion is mediated via the nucleus tractus solitarius. Horm. Metab. Res. 1992;24:103–105
  8. Ellison EC, Pappas TT, Pace WG, O’Dorisio TM. Apparatus for long term ventricular access in the awake canine. J. Appl. Physiol. 1986;61:368–372
  9. Geoghegan JG, Lawson DC, Cheng CA, Opara E, Taylor IL, Pappas TN. Intracerebroventricular neuropeptide Y increases gastric and pancreatic secretion in the dog. Gastroenterology. 1993;105:1069–1077
  10. Goodman MH. Hormonal regulation of fuel metabolism. In:  Goodman MH editors. Basic Medical Endocrinology. third ed.. Elsevier; 2003;p. 291–325
  11. Guzman S, Chayvialle JA, Banks WA, Rayford PL, Thompson JC. Effect of vagal stimulation on pancreatic secretion and on blood levels of gastrin, cholecystokinin, secretin, vasoactive intestinal peptide and somatostatin. Surgery. 1979;86:329–336
  12. Humphrey CS, Murray P, Ebeid AM, Fischer JE. Hepatic and pulmonary clearance of exogenous vasoactive intestinal peptide in the rat. Gastroenterology. 1979;77:55–60
  13. Kuenzel WJ, Mc Murtry J. Neuropeptide Y: brain localization and central effects on plasma insulin levels in chicks. Physiol. Behav. 1988;44:669–678
  14. Lee MC, Lawson DC, Pappas TN. Neuropeptide Y functions as a physiologic regulator of cephalic phase acid secretion. Regul. Pept. 1994;52:227–234
  15. Moltz JH, McDonald JK. Neuropeptide Y: direct and indirect action on insulin secretion in the rat. Peptides. 1985;6:1155–1159
  16. Norman AW, Litwack G. Gastrointestinal hormones. In:  Norman AW,  Litwack G editor. Hormones. second ed.. Elsevier; 1997;p. 229–249
  17. O’Connor AM, Pola S, Ward BM, Fillmore D, Buchanan KD, Kirwan JP. The gastroenteroinsular response to glucose ingestion during postexercise recovery. Am. J. Physiol. Endocrinol. Metab. 2006;290:1155–1161
  18. Sheikh SP, Holst JJ, Skak-Nielsen T, Knigge U, Warberg J, Theodorsson-Norheim E, et al. Release of NPY in pig pancreas: dual parasympathetic and sympathetic regulation. Am. J. Physiol. 1988;255:46–54
  19. Strubbe JH, Prins AJ, Bruggink J, Steffens AB. Daily variation of food-induced changes in blood glucose and insulin in the rat and the control by the suprachiasmatic nucleus and the vagus nerve. J. Auton. Nerv. Syst. 1987;20:113–119
  20. Szecówka J, Sandberg E, Efendić , S . The interaction of vasoactive intestinal polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas. Diabetologia. 1980;19:137–142
  21. Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B. Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia. 1994;37:1202–1208
  22. Wilding IP, Kruszynska YT, Lambert PD, Bloom SR. Acute effects of central neuropeptide Y injection on glucose metabolism in fasted rats. Clin. Sci. (Colch). 1995;89:543–548
  23. Wilson DA, O’Neill JT, Said SI, Traystman RJ. Vasoactive intestinal polypeptide and the canine cerebral circulation. Circ. Res. 1981;48:138–148
  24. Winzell MS, Ahrén B. Role of VIP and PACAP in islet function. Peptides. 2007;28:1805–1813
  25. Woods SC, Porte D, Bobbioni E, Ionescu E, Sauter JF, Rohner-Jeanrenaud F, et al. Insulin: its relationship to the central nervous system and to the control of food intake and body weight. Am. J. Clin. Nutr. 1985;42:1063–1071
  26. Yovos JG, O’Dorisio TM, Gaginella TS, Cataland S, Carey LC. Development and validation of an in vivo brain–gut peptide model. Regul. Pept. 1983;(Suppl.):222
  27. Zeng N, Athmann C, Kang T, Lyu RM, Walsh JH, Ohning GV, et al. PACAP type I receptor activation regulates ECL cells and gastric acid secretion. J. Clin. Invest. 1999;104:1383–1391

PII: S0143-4179(08)00112-1

doi: 10.1016/j.npep.2008.10.001

Neuropeptides
Volume 43, Issue 1 , Pages 41-46 , February 2009

Article Tools

* Image Usage & Resolution